Joaquin Tosi
Retina Specialist · Virginia Beach, VANPI 1306158381
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Spark Therapeutics, Inc. at 44.3% of the total. Reporting peaked in 2019 at $22,136 and has fallen 96.4% since, to $803 in 2025. Among retina specialist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $192.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spark Therapeutics, Inc.$21K
- Genentech, Inc.$9K
- Genentech USA, Inc.$8K
- Alimera Sciences, Inc.$3K
- Eyepoint US, Inc.$2K
- Mallinckrodt Hospital Products Inc.$1K
- plus $3K from 16 others
Across 20 payments — averaging $14,303 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$286K
What the payments were for
- Consulting fees$13,64028%
- Speaking & faculty fees$19,87541%
- Travel & lodging$5,84512%
- Food & beverage$8,83218%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spark Therapeutics, Inc. | 15 | $21,333 |
| Genentech, Inc. | 12 | $9,064 |
| Genentech USA, Inc. | 34 | $8,026 |
| Alimera Sciences, Inc. | 32 | $2,948 |
| Eyepoint US, Inc. | 23 | $2,438 |
| Mallinckrodt Hospital Products Inc. | 29 | $1,077 |
| Regeneron Healthcare Solutions, Inc. | 30 | $1,030 |
| AbbVie(2 entities) | 21 | $601 |
| Coherus Oncology, Inc. | 14 | $339 |
| Alcon | 3 | $336 |
| Sandoz | 11 | $218 |
| Apellis Pharmaceuticals, Inc. | 5 | $194 |
| ANI Pharmaceuticals, Inc. | 4 | $165 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $93 |
| Astellas Pharma US Inc | 4 | $91 |
| Bausch & Lomb Americas Inc. | 4 | $87 |
| Harrow Eye, LLC | 2 | $50 |
| Biogen | 2 | $28 |
| Neurotech Pharmaceuticals, Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$48,193 in reported general payments places this provider in the 95th percentile of 41 retina specialist providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 22 | $4,427 |
| Prednisolone Acetate | 98 | $4,065 |
| Ketorolac Tromethamine | 97 | $2,787 |
| Brimonidine Tartrate | 63 | $572 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 40 | $531 |
| Timolol Maleate | 27 | $376 |
| Latanoprost | 35 | $354 |
| Dorzolamide Hcl | 14 | $215 |
| Prednisone | 13 | $117 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCombigan | $601 | $4,42722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 41 retina specialist providers in Virginia.
Other retina specialist in Virginia Beach
- Jordana FeinManassas$412K
- Mohit NandaCharlottesville$31K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
- Dal ChunVienna$12K
- Kori ElkinsPortsmouth$9K
- Jiwei ShengFairfax$8K
- Timothy ByrnesRoanoke$7K
- Alexander MelamudFairfax$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.